trending Market Intelligence /marketintelligence/en/news-insights/trending/3OlHgjBr2Zarp4JV1fdlHA2 content esgSubNav
In This List

Amphion Innovations ups Motif Bio stake to 22%

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Amphion Innovations ups Motif Bio stake to 22%

Amphion Innovations Plc and Amphion Innovations U.S. Inc. raised their stake in Motif Bio PLC to 22% after opting to convert the company's debt into shares.

Motif will issue 14,510,770 shares priced at 24.47 cents apiece as a result, representing a value of $3.6 million.